Dr. Posner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
235 E 42nd St
Mailstop: Nyo-235-09-01
New York, NY 10017Phone+1 212-733-7557Fax+1 646-441-6032
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1998 - 1999- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1995 - 1998
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1993 - 1995
Albert Einstein College of MedicineClass of 1993
Clinical Trials
- Donepezil Hydrochloride (E2020) in Dementia Associated With Cerebrovascular Disease Start of enrollment: 2003 Mar 01
Publications & Presentations
PubMed
- 2 citationsSafety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study.Hermine I Brunner, Jonathan D Akikusa, Eslam Al-Abadi, John F Bohnsack, Alina Lucica Boteanu
Annals of the Rheumatic Diseases. 2024-10-21 - A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia are...Samira Anderson, Guido Cavaletti, Linda J Hood, Michael Polydefkis, David N Herrmann
Pharmacology Research & Perspectives. 2024-08-01 - Tofacitinib for juvenile idiopathic arthritis - Authors' reply.Nicolino Ruperto, Hermine I Brunner, Holly B Posner, Irina Lazariciu, Alberto Martini
Lancet. 2022-05-14
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
